Stockreport

ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance [Yahoo! Finance]

ADMA Biologics Inc  (ADMA) 
Last adma biologics inc earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.admabiologics.com
PDF ADMA Biologics, Inc. (NASDAQ:ADMA) markets BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency, and Nabi-HB, [Read more]